Abstract
Bone tissues have trabecular bone with a high bone turnover and cortical bone with a low turnover. The mechanisms by which the turnover rate of these bone tissues is determined remain unclear. Osteocytes secrete sclerostin, a Wnt/β-catenin signaling antagonist, and inhibit bone formation. We found that sclerostin expression in cortical bone is more marked than in trabecular bone in Sost reporter mice. Leukemia inhibitory factor (LIF) secreted from osteoclasts reportedly suppressed sclerostin expression and promoted bone formation. Here, we report that osteoclasts downregulate sclerostin expression in trabecular bone and promote bone turnover. Treatment of C57BL/6 mice with an anti-RANKL antibody eliminated the number of osteoclasts and LIF-positive cells in trabecular bone. The number of sclerostin-positive cells was increased in trabecular bone, while the number of β-catenin-positive cells and bone formation were decreased in trabecular bone. Besides, Tnfsf11 heterozygous (Rankl+/−) mice exhibited a decreased number of LIF-positive cells and increased number of sclerostin-positive cells in trabecular bone. Rankl+/− mice exhibited a decreased number of β-catenin-positive cells and reduced bone formation in trabecular bone. Furthermore, in cultured osteoclasts, RANKL stimulation increased Lif mRNA expression, suggesting that RANKL signal increased LIF expression. In conclusion, osteoclasts downregulate sclerostin expression and promote trabecular bone turnover.
Highlights
Increase bone mass with increased bone formation[16,17]
We previously reported that leukemia inhibitory factor (LIF) derived from osteoclasts suppressed sclerostin expression in osteocytes[8]
In order to evaluate whether LIF expression is suppressed by the elimination of bone resorption, we examined the LIF expression in trabecular bone of C57BL/6 male mice injected with the anti-RANKL antibody
Summary
Increase bone mass with increased bone formation[16,17]. These findings indicate that the reduction of sclerostin expression increases bone formation. We demonstrated that osteoclast-secreted LIF suppressed sclerostin expression and accelerated bone formation in vitro and in vivo[8]. The trabecular bone was remodeled at a high turnover rate that was likely affected by alterations in the Wnt/β-catenin signaling pathway[26]. It is unclear how bone turnover is controlled. We found that the treatment of C57BL/6 mice with an anti-RANKL antibody upregulated sclerostin expression in trabecular bone and reduced the number of osteoclasts. Treatment with the anti-RANKL antibody reduced the number of β-catenin-positive cells and bone formation in trabecular bone. Tnfsf[11] heterozygous (Rankl+/−) mice, in which bone resorption is suppressed, exhibited increased numbers of sclerostin-positive cells in trabecular bone. The suppression of sclerostin expression by osteoclasts plays a critical role in bone formation in trabecular bone
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.